Craft

Zimmer Biomet

Stock Price

$121.7

2024-01-26

Market Capitalization

$25.4 B

2024-01-26

Revenue

$6.9 B

FY, 2022

Zimmer Biomet Summary

Company Summary

Overview
Zimmer Biomet Holdings is a medical technology company that develops implants as well as digital technology and infrastructure. It designs, manufactures, and markets orthopedic reconstructive products, sports medicine, biologics, extremities and trauma products, spine, craniomaxillofacial and thoracic products, and related surgical products. The company helps treat patients suffering from disorders of, or injuries to, bones, joints, and supporting soft tissues.
Type
Public
Status
Active
Founded
1927
HQ
Warsaw, IN, US | view all locations
Website
https://www.zimmerbiomet.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Ivan Tornos

    Ivan Tornos, President and Chief Executive Officer

  • Angela Main

    Angela Main, Senior Vice President, Global Chief Compliance Officer and Associate General Counsel, Asia Pacific

  • Rachel Ellingson

    Rachel Ellingson, Senior Vice President and Chief Strategy Officer

  • Zeeshan Tariq

    Zeeshan Tariq, Senior Vice President and Chief Information Officer

Operating MetricsView all

Countries (Facilities)

45

FY, 2022

Manufacturing Facilities

25
28.6%

FY, 2022

Facilities

280
17.6%

FY, 2022

LocationsView all

57 locations detected

  • Warsaw, IN HQ

    United States

    1800 W Center St

  • Carlsbad, CA

    United States

    1900 Aston Ave

  • Dover, OH

    United States

    200 W Ohio Ave

  • Miami, FL

    United States

    6303 Blue Lagoon Dr

  • Warsaw, IN

    United States

    P.O. Box 708

  • Westminster, CO

    United States

    10225 W More Drive

and 51 others

Zimmer Biomet Financials

Summary Financials

Revenue (Q3, 2023)
$1.8B
Gross profit (Q3, 2023)
$1.2B
Net income (Q3, 2023)
$162.9M
Cash (Q3, 2023)
$292.1M
EBIT (Q3, 2023)
$266.6M
Enterprise value
$30.6B

Footer menu